Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Apr 30;330(7498):1003.
doi: 10.1136/bmj.330.7498.1003.

Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care

Affiliations
Clinical Trial

Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care

Jill Porthouse et al. BMJ. .

Abstract

Objective: To assess whether supplementation with calcium and cholecaliferol (vitamin D3) reduces the risk of fracture in women with one or more risk factors for fracture of the hip.

Design: Pragmatic open randomised controlled trial.

Setting: Practice nurse led clinics in primary care.

Participants: 3314 women aged 70 and over with one or more risk factors for hip fracture: any previous fracture, low body weight (< 58 kg), smoker, family history of hip fracture, or fair or poor self reported health.

Intervention: Daily oral supplementation using 1000 mg calcium with 800 IU cholecaliferol and information leaflet on dietary calcium intake and prevention of falls, or leaflet only (control group).

Main outcome measures: Primary outcome measure was all clinical fractures and secondary outcome measures were adherence to treatment, falls, and quality of life (measured with the SF-12).

Results: 69% of the women who completed the follow-up questionnaire at 24 months were still taking supplements (55% with inclusion of randomised participants known to be alive). After a median follow-up of 25 months (range 18 to 42 months), clinical fracture rates were lower than expected in both groups but did not significantly differ for all clinical fractures (odds ratio for fracture in supplemented group 1.01, 95% confidence interval 0.71 to 1.43). The odds ratio for hip fracture was 0.75 (0.31 to 1.78). The odds of a woman having a fall at six and 12 months was 0.99 and 0.98, respectively. Quality of life did not significantly differ between the groups.

Conclusion: We found no evidence that calcium and vitamin D supplementation reduces the risk of clinical fractures in women with one or more risk factors for hip fracture. Registration ISRCTN26118436, controlled trials registry.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Flow of participants through trial. Adherence was estimated by subtracting those known to have died. Those who failed to return questionnaires were assumed not to be taking treatment
Fig 2
Fig 2
Time to first fracture in women allocated calcium and vitamin D supplementation or only advice on diet and prevention of falls

Comment in

References

    1. Schurch MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP. A prospective study on the socio-economic aspects of fracture of the proximal femur. J Bone Miner Res 1996:11: 1935-42. - PubMed
    1. Barret-Connor E. The economic and human costs of osteoporotic fracture. Am J Med 1993:98(suppl 2a): S3-7. - PubMed
    1. Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 1998;6: 11-7. - PubMed
    1. Grimley-Evans J, Seagroatt V, Goldacre MJ. Secular trends in proximal femoral fracture: Oxford record linkage study area and England 1968-86. J Epidemiol Community Health 1997;51: 424-9. - PMC - PubMed
    1. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327: 1637-42. - PubMed

Publication types

Associated data